chr5-128393267-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2
The ENST00000262464.9(FBN2):āc.1333A>Gā(p.Ser445Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000205 in 1,461,838 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000262464.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBN2 | NM_001999.4 | c.1333A>G | p.Ser445Gly | missense_variant | 10/65 | ENST00000262464.9 | NP_001990.2 | |
FBN2 | XM_017009228.3 | c.1180A>G | p.Ser394Gly | missense_variant | 9/64 | XP_016864717.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBN2 | ENST00000262464.9 | c.1333A>G | p.Ser445Gly | missense_variant | 10/65 | 1 | NM_001999.4 | ENSP00000262464 | P1 | |
FBN2 | ENST00000508989.5 | c.1234A>G | p.Ser412Gly | missense_variant | 9/33 | 2 | ENSP00000425596 | |||
FBN2 | ENST00000703787.1 | n.1040A>G | non_coding_transcript_exon_variant | 9/10 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 250950Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135600
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461838Hom.: 0 Cov.: 31 AF XY: 0.0000289 AC XY: 21AN XY: 727224
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 17, 2021 | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function; Does not affect a cysteine residue within a calcium-binding EGF-like domain of the FBN2 gene; cysteine substitutions in the calcium-binding EGF-like domains represent the majority of pathogenic missense changes associated with FBN2-related disorders (Frederic et al., 2009).; This variant is associated with the following publications: (PMID: 26582918, 18767143, 27535533) - |
Congenital contractural arachnodactyly Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 08, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at